BAYER AG-Exch receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bayer AG NA (BAYGn)
Assess today's live Bayer AG NA (BAYGn) share price, performance and insights using our live Xetra: BAYGn stock exchange data.
Analyse the historical data and Bayer AG NA share price performance charts on this page. Our technical summary section provides analysis on Bayer share price buy/sell indicators using real-time data (or discuss the Bayer (BAYGn) stock price today with other investors in the Bayer ETR share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ETR BAYGn share price (ISIN: DE000BAY0017) to enhance your trading decisions with our free investment tools and resources.
What Is the Bayer AG NA Share Price Today?
The Bayer share price today is 44.56.
What Is the Stock Symbol for Bayer AG NA
The stock symbol (or 'ticker') for Bayer AG NA is "BAYGn."
What Stock Exchange Does Bayer AG NA Trade On?
Bayer AG NA is listed and trades on the Xetra stock exchange.
Is Bayer AG NA a Good Stock to Buy?
Determining whether Bayer AG NA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Bayer AG NA share price performance charts on this page. Our technical summary section provides analysis on Bayer share price buy/sell indicators using real-time data (or discuss the Bayer (BAYGn) stock price today with other investors in the Bayer ETR share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ETR BAYGn share price (ISIN: DE000BAY0017) to enhance your trading decisions with our free investment tools and resources.
What Is the Bayer AG NA Share Price Today?
The Bayer share price today is 44.56.
What Is the Stock Symbol for Bayer AG NA
The stock symbol (or 'ticker') for Bayer AG NA is "BAYGn."
What Stock Exchange Does Bayer AG NA Trade On?
Bayer AG NA is listed and trades on the Xetra stock exchange.
Is Bayer AG NA a Good Stock to Buy?
Determining whether Bayer AG NA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Real-time derived
Symbol | Exchange | Currency | |||
|---|---|---|---|---|---|
| BAYGN | · | Derived | · | EUR | |
| BAYGn | · | Xetra | · | EUR | |
| BAYNd | · | BATS Europe | · | EUR | |
| BAYRY | · | OTC Markets | · | USD | |
| 0P6S | · | London | · | EUR | |
| BAYNN | · | Mexico | · | MXN | |
| BAYNN | · | BIVA | · | MXN | |
| BAYG | · | Milan | · | EUR | |
| BAYGn | · | Switzerland | · | CHF | |
| BAYGn | · | Hamburg | · | EUR | |
| BAYGn | · | TradeGate | · | EUR | |
| BAYGn | · | Dusseldorf | · | EUR | |
| BAYGn | · | Frankfurt | · | EUR | |
| BAY1 | · | Warsaw | · | PLN | |
| BAYGn | · | Vienna | · | EUR | |
| BAYG | · | Budapest | · | HUF | |
| BAYN | · | Bucharest | · | RON |
Currency in EUR
44.56
+0.39(+0.88%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
43.99
44.99
52 wk Range
18.38
44.99
Trading near 52-week High
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
43.9944.99
52 wk Range
18.3844.99
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.25%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.25%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BAYGn Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
40.98
Downside
-8.05%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings upwards for the upcoming period
- BAYER AG-Exch receives Investment Bank Analyst Rating Update
- Investing.com
Pro - BAYER AG-Exch receives Investment Bank Analyst Rating Update
- Investing.com
Pro - BAYER AG-Exch receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- BAYER AG-Exch receives Investment Bank Analyst Rating Update
- Investing.com
Pro - BAYER AG-Exch receives Investment Bank Analyst Rating Update
- Investing.com
Pro - BAYER AG-Exch receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Bayer Company Profile
Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, pain and cardiovascular risk prevention products, digestive health products, allergy products, and cold and cough products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
Compare BAYGn to Peers and Sector
Metrics to compare | BAYGn | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBAYGnPeersSector | |
|---|---|---|---|---|
P/E Ratio | −221.1x | −2.7x | −0.6x | |
PEG Ratio | −2.85 | 0.00 | 0.00 | |
Price/Book | 1.5x | 1.4x | 2.6x | |
Price / LTM Sales | 1.0x | 0.7x | 3.4x | |
Upside (Analyst Target) | −8.0% | 31.3% | 42.0% | |
Fair Value Upside | Unlock | −11.0% | 5.0% | Unlock |
Analyst Ratings
12 Buy
8 Hold
0 Sell
Ratings:
20 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 40.98
(-8.05% Downside)
Earnings
Latest Release
Nov 12, 2025
EPS / Forecast
0.57 / 0.3663
Revenue / Forecast
9.66B / 9.69B
People Also Watch
FAQ
What Is the Bayer (BAYGn) Share Price Today?
The live Bayer share price today is 44.56
What Stock Exchange Does Bayer (BAYGn) Trade On?
Bayer is listed and trades on the Frankfurt Stock Exchange.
What Is the Ticker (Stock Symbol) for Bayer?
The stock symbol (also called a 'ticker') for Bayer is "BAYGn."
Does Bayer Pay Dividends? What’s The Current BAYGn Dividend Yield?
Yes, BAYGn Pays Dividends to its Shareholders. The current Bayer dividend yield is 0.25%.
What Is the Current Bayer Market Cap?
As of today, Bayer market capitalisation is 43.77B.
What Is Bayer's (BAYGn) Earnings Per Share (TTM)?
The Bayer EPS is currently -0.20 (Trailing Twelve Months).
When Is the Next Bayer Earnings Date?
Bayer's next earnings report will be released on 25 Feb 2026.
Is BAYGn a Buy or Sell From a Technical Analyst Perspective?
Based on today's Bayer moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Bayer Stock Split?
Bayer has split 3 times. (See the BAYGn stock split history page for full effective split date and price information.)
How Many Employees Does Bayer Have?
Bayer has 88502 employees.
What is the current trading status of Bayer (BAYGn)?
As of 24 Jan 2026, Bayer (BAYGn) is trading at a price of 44.56, with a previous close of 44.56. The stock has fluctuated within a day range of 43.99 to 44.99, while its 52-week range spans from 18.38 to 44.99.
What Is Bayer (BAYGn) Price Target According to Analysts?
The average 12-month price target for Bayer is EUR40.98, with a high estimate of EUR55 and a low estimate of EUR23. 12 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an -8.05% Downside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.